Switzerland-based drugs company Debiopharm Group has acquired a minority equity stake in local electronic marketing platform Tweasy for an undisclosed amount.

José de Bastos, chief executive of Tweasy, said: “Thanks to the Debiopharm Group, we will be able to graduate from the incubation period and accelerate our development. In practical terms, we are going to fine-tune the online platform, develop the mobile channels and begin our international expansion. Our purpose is clearly to offer the best digital toolbox on the market”.

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?